Expression of interferon-stimulated gene 20 (ISG20), an antiviral effector protein, in glomerular endothelial cells: possible involvement of ISG20 in lupus nephritis

References

• Lai AS, Lai KN. Viral nephropathy. Nat Clin Pract Nephrol. 2006;2(5):1–8. doi: 10.1038/ncpneph0166.
   PubMedGoogle Scholar
• Anders HJ, Banas B, Schlöndorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004;15(4):854–867. doi: 10.1097/01.asn.0000121781.89599.16.
   PubMed Web of Science ®Google Scholar
• Sepe V, Libetta C, Gregorini M, et al. The innate immune system in human kidney inflammaging. J Nephrol. 2022;35(2):381–395. doi: 10.1007/s40620-021-01153-4.
   PubMed Web of Science ®Google Scholar
• Yoshimoto S, Nakatani K, Iwano M, et al. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis. Am J Kidney Dis. 2007;50(1):47–58. doi: 10.1053/j.ajkd.2007.04.012.
   PubMed Web of Science ®Google Scholar
• Hirono K, Imaizumi T, Aizawa T, et al. Endothelial expression of fractalkine (CX3CL1) is induced by toll-like receptor 3 signaling in cultured human glomerular endothelial cells. Mod Rheumatol. 2020;30(6):1074–1081. doi: 10.1080/14397595.2019.1682768.
   PubMed Web of Science ®Google Scholar
• Ding X, Ren Y, He X. IFN-I mediates lupus nephritis from the beginning to renal fibrosis. Front Immunol. 2021;12:676082. doi: 10.3389/fimmu.2021.676082.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13(5):816–825. doi: 10.1038/sj.cdd.4401850.
   PubMed Web of Science ®Google Scholar
• Anders HS. Pseudoviral immunity - a novel concept for lupus. Trends Mol Med. 2009;15(12):553–561. doi: 10.1016/j.molmed.2009.10.004.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Imaizumi T. Inflammatory chemokine expression via toll-like receptor 3 signaling in normal human mesangial cells. Clin Dev Immunol. 2013;2013:984708. doi: 10.1155/2013/984708.
   PubMedGoogle Scholar
• Watanabe S, Imaizumi T, Tsuruga K, et al. Glomerular expression of myxovirus resistance protein 1 (Mx1) in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis. Nephrology (Carlton). 2013;18(12):833–837. doi: 10.1111/nep.12155.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Aizawa T, Segawa C, et al. Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1, in human mesangial cells. Clin Exp Nephrol. 2015;19(5):761–770. doi: 10.1007/s10157-014-1060-4.
   PubMed Web of Science ®Google Scholar
• Lorenz G, Lech M, Anders HJ. Toll-like receptor activation in the pathogenesis of lupus nephritis. Clin Immunol. 2017;185:86–94. doi: 10.1016/j.clim.2016.07.015.
   PubMed Web of Science ®Google Scholar
• Conti F, Spinelli FR, Truglia S, et al. Kidney expression of toll-like receptors in lupus nephritis: quantification and clinicopathological correlations. Mediators Inflamm. 2016;2016:7697592. doi: 10.1155/2016/7697592.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Yano C, Numata A, et al. Interferon (IFN)-induced protein 35 (IFI35), a type I interferon-dependent transcript, upregulates inflammatory signaling pathways by activating toll-like receptor 3 in human mesangial cells. Kidney Blood Press Res. 2016;41(5):635–642. doi: 10.1159/000447932.
   PubMed Web of Science ®Google Scholar
• Hashimoto S, Imaizumi T, Aizawa T, et al. Expression of IFN-induced transmembrane protein 1 in glomerular endothelial cells. Pediatr Int. 2021;63(9):1075–1081. doi: 10.1111/ped.14579.
   PubMed Web of Science ®Google Scholar
• Karasawa T, Sato R, Imaizumi T, et al. Glomerular endothelial expression of type I IFN-stimulated gene, DExD/H-Box helicase 60 via toll-like receptor 3 signaling: possible involvement in the pathogenesis of lupus nephritis. Ren Fail. 2022;44(1):137–145. doi: 10.1080/0886022X.2022.2027249.
   PubMed Web of Science ®Google Scholar
• Crosse KM, Monson EA, Beard MR, et al. Interferon-stimulated genes as enhancers of antiviral signaling. J Innate Immun. 2018;10(2):85–93. doi: 10.1159/000484258.
   PubMed Web of Science ®Google Scholar
• Espert L, Degols G, Gongora C, et al. ISG20, a new interferon-induced RNase specific for single-stranded RNA, defines an alternative antiviral pathway against RNA. J Biol Chem. 2003;278(18):16151–16158. doi: 10.1074/jbc.M209628200.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Shimada T, Matsumiya T, et al. Interferon-stimulated gene 15, a type I interferon-dependent transcript, is involved in a negative feedback loop in innate immune reactions in human mesangial cells. Nephron. 2016;132(2):144–152. doi: 10.1159/000443934.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Tanaka H, Mechti N, et al. Polyinosinic-polycytidylic acid induces the expression of interferon-stimulated gene 20 in mesangial cells. Nephron Exp Nephrol. 2011;119(2):e40–e48. doi: 10.1159/000328923.
   PubMedGoogle Scholar
• Aizawa-Yashiro T, Imaizumi T, Tsuruga K, et al. Glomerular expression of fractalkine is induced by polyinosinic-polycytidylic acid in human mesangial cells: possible involvement of fractalkine after viral infection. Pediatr Res. 2013;73(2):180–186. doi: 10.1038/pr.2012.165.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Vielhauer V, Schlöndorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int. 2003;63(2):401–415. doi: 10.1046/j.1523-1755.2003.00750.x.
   PubMed Web of Science ®Google Scholar
• Weiss CM, Trobaugh DW, Sun C, et al. The interferon-induced exonuclease ISG20 exerts antiviral activity through upregulation of type I interferon response proteins. mSphere. 2018;3(5):e00209–e00218. doi: 10.1128/mSphere.00209-18.
   PubMed Web of Science ®Google Scholar
• Gao M, Lin Y, Liu X, et al. ISG20 promotes local tumor immunity and contributes to poor survival in human glioma. Oncoimmunol. 2019;8(2):e1534038. doi: 10.1080/2162402X.2018.1534038.
   PubMed Web of Science ®Google Scholar